This study was conducted to investigate the efficacy and safety of ultrasound (US)-targeted microbubble (MB) destruction (UTMD)-mediated rAAV2-CMV-EGFP transfection to cultured human retinal pigment epithelium (RPE) cells in vitro and to the rat retina in vivo. In the in vitro study, cultured human RPE cells were exposed to US under different conditions with or without MBs. Furthermore, the effect of UTMD on rAAV2-CMV-EGFP itself and on cells was evaluated. In the in vivo study, gene transfer was examined by injecting rAAV2-CMV-EGFP into the subretinal space of rats with or without MBs and then exposed to US. We investigated enhanced green fluorescent protein (EGFP) expression in vivo by stereomicroscopy and performed quantitative analysis using Axiovision 3.1 software.
Introduction
Many inherited and acquired retinal diseases have become the leading causes of blindness in adults, and retinal pigment epithelium (RPE) cells are believed to be involved in the pathogenesis of some such diseases, such as retinitis pigmentosa, Leber Congenital Amaurosis and proliferative vitreoretinopathy. 1, 2 Currently, there is no satisfactory treatment available for these disorders. Gene therapy represents a promising therapeutic option for these diseases. One of the most critical areas of gene therapy is the design of an appropriate, accurate and effective gene transfer system that can be safely applied in vivo. Adeno-associated virus (AAV) vectors have a number of important advantages over other vectors, which make them suitable for transfection studies, in particular the ability to induce long-term transgene expression in the eye and a relative lack of pathogenicity. 1, 3, 4 However, the transduction of AAV occurs with relatively low efficiency, which limits its therapeutic effects. Increasing AAV transduction may produce better therapeutic effects. [5] [6] [7] Ultrasound (US)-targeted microbubble (MB) destruction (UTMD) has been proved to enhance gene transfer in various studies in vitro and in vivo. UTMD could serve as a potential site-specific gene transfer modality, but the mechanism is not definite. Sonoporation, which can transiently enhance the permeability of cell membranes to introduce genes into cells by exposing them to US, is considered to have a key role, and MBs acting as cavitation nuclei can effectively focus US energy and further potentiate bioeffects. [8] [9] [10] [11] Recent reports show that US/MBs can be used safely and efficiently in many models of diseases in various organs. 12 As far as we know, in the sphere of ophthalmology, scholars pay much attention to study US-mediated transfection (USMT) or UTMD on the cornea, [13] [14] [15] [16] [17] but few report on the retina. Moreover, US/MB-mediated transduction mainly focuses on plasmid DNA, few reports have been published with regard to US/MBs and AAV. Thus, we considered the possibility of whether UTMD could increase rAAV2-EGFP transfection to the retina, as UTMD could greatly increase plasmid-DNA transfer to the corneal cells in vivo and in vitro.
Results
In vitro study Gene transfer by US. Intensities of US and exposure time were set at 1, 2 and 3 W cm
À2
, and at 60 and 120 s, respectively (50% duty cycle). There was no difference between the US exposure groups and the control group (P40.05, Figure 1a ).
Gene transfer by MBs. The ratios of MBs to cells that we selected for our study were 40:1 and 50:1. There was no difference between those groups in which cells were treated with MBs and the control group (P40.05, Figure 1b) .
Gene transfer by US and MBs. To identify the optimal conditions required to transfer rAAV2-CMV-EGFP by US using MBs, the following four parameters were examined.
Pulse wave and continuous wave. Pulse wave and continuous wave were examined under an intensity of 2 W cm À2 for 60 s with MBs (the ratio of MBs to cells was 50:1). Three duty cycles (10, 20 and 50%) of pulse wave and continuous wave were studied. Under the condition of 50% duty cycle, UTMD could significantly enhance transfection efficiency compared with the control group, and with 10 and 20% duty cycle groups (P ¼ 0.000, 0.000 and 0.001, respectively, Figure 2a ). Although UTMD could significantly enhance transfection efficiency under the condition of continuous wave (P ¼ 0.000), cell damage was severe ( Figure 2c ) and cell viability was significantly lower than that of the 50% duty cycle group (P ¼ 0.000).
Microbubbles. Five ratios of MBs to cells (20:1, 30:1, 40:1, 50:1 and 60:1) were examined under the US condition of 1 W cm À2 , 60 s and 50% duty cycle. The increased percentage of transfection efficiency in the 50:1 group was significantly greater than that in 20:1, 30:1 and 40:1 groups (P ¼ 0.000, 0.000 and 0.000, respectively, Figure 3a ). There was no difference between the ratios of 50:1and 60:1 (P40.05).
US intensity and exposure time. The US intensities of 1, 2 and 3 W cm
, and the exposure time of 60 and 120 s were examined (50% duty cycle and the ratio of MBs to cells being 50:1). The ratio of enhanced green fluorescent protein (EGFP)-positive cells in the UTMD (US+MBs) group was significantly higher than that of the corresponding USMT (US) group (P ¼ 0.000, Figure 3b ). In the UTMD group, there was no difference between 1 W cm
, 60 s and other conditions (P40.05). The ratio of EGFP-positive cells under the condition of 1 W cm À2 , 60 s was significantly higher than that of the control group (P ¼ 0.000).
The effect of UTMD on rAAV2-CMV-EGFP. The effect of UTMD on rAAV2-CMV-EGFP itself was evaluated by the transfection efficiency of the cells after UTMD. There was no difference between the experimental groups (power: 1 and 3 W cm
; 50% duty cycle; 60 and 120 s; the ratio of MBs to cells was 50:1) and the control group (P40.05, Figure 4 ). Figure 5 ). Cell viability under the condition of 2 W cm À2 was significantly lower than that under the condition of 1 W cm À2 (P ¼ 0.018, Figure 5 ).
Cell

In vivo study
(1) The number of EGFP-positive rats on day 4: The number of EGFP-positive rats in Group 4 was significantly higher than that in other groups (P ¼ 0.029, Table 1 ). (2) Enhanced green fluorescent protein expressions of the four groups at different time points ( Figure 6 ): The quantity of fluorescence in Group 4, in which AAV was combined with US and MBs (AAV+MB+US), was significantly higher than that of the other three groups (AAV, AAV+MB and AAV+US) on day 4 (P ¼ 0.000, 0.000 and 0.000, respectively), day 7 (P ¼ 0.000, 0.000 and 0.000, respectively) and day 35 (P ¼ 0.001, 0.003 and 0.013, respectively), and there was no difference on the days 49 and 120 (Figure 6a , P40.05). There was no difference between Group 2 (AAV+MB), Group 3 (AAV+US) and Group 1 (AAV) (P40.05). EGFP expression increased from day 7 to day 35, and fell from day 49 to day 120 ( Figure 6b ). The ratios of enhanced green fluorescent protein (EGFP)-positive cells in the US-targeted MB destruction (UTMD) (US+MBs) group was significantly higher than that in the corresponding US-mediated transfection (US) group (P ¼ 0.000). In UTMD group, there was no difference between the 1 W cm À2 , 60 s group and other groups (P40.05). *Po0.05. Figure 4 The effect of ultrasound-targeted microbubble destruction on rAAV2-EGFP itself. There was no difference between the experimental groups and the control group (P40.05).
Figure 5
Cell damage under the condition of 1, 2 and 3 W cm À2 , 50% duty cycle, 120 s, with the ratio of MBs to cells being 50:1. Cell viability under the condition of 3 W cm À2 was significantly lower than that under the condition of 1 and 2 W cm À2 (P ¼ 0.000 and 0.000, respectively). Cell viability under the condition of 2 W cm À2 was significantly lower than that under the condition of 1 W cm À2 (P ¼ 0.018). *Po0.05.
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Discussion
Gene therapy can potentially correct inherited and acquired diseases of the retina. The retina has structure and accessibility properties that make it an ideal target organ for genetic therapies. Moreover, in the last two decades, over 130 genes have been identified to cause retinal diseases and many animal models have also been built. 1, 3, [18] [19] [20] [21] Recently, the potential for gene delivery to the eye using AAV vectors has received much attention. 1, 3, 4 However, the transfection of AAV occurs with a relatively low efficiency and a later expression in some tissues, which limits its therapeutic effects. Several methods to increase the transfection efficiency of AAV vectors have been explored, such as a combinational use with an adenovirus or with a chemotherapy drug. 6 However, the above strategies have many limitations. We used sodium butyrate combined with rAAV2-CMV-EGFP to transfect RPE cells in vitro. We achieved a higher transfection efficiency, but also a higher cell death rate (data not shown). A new and improved method of delivery is required to augment the efficiency of AAV infection.
Ultrasound/MB-associated local gene therapy has the potential for not only plasmid-DNA, but also virusmediated gene transfer, similar to adenovirus, AAV and retrovirus. [22] [23] [24] [25] [26] [27] Shohet et al. 23 demonstrated a successful transfection of rat myocardium in vivo by UTMD of MBs containing an adenovirus encoding a beta-galactosidase reporter gene. Transfection efficiencies by US with retrovirus were enhanced 6.6-fold, 4.8-fold, 2.3-fold and 3.2-fold in 293T cells, BAECs, RASMCs and L6 cells, respectively. 25 Recent research outcomes showed that UTMD could augment cardiac transfection of AAV vectors after intravenous administration in rats. UTMD significantly increased cardiac reporter activities 6-20-fold than in control rats, which received the same amount of virus without MBs, but with US. 22 Our findings indicated that UTMD could exert a significant enhancing effect on rAAV2-mediated gene expression in RPE cells. To establish the optimal conditions of UTMD-mediated gene transfer to human RPE cells, various US conditions were examined. First, the duty cycle of US was evaluated. Results clearly showed that a continuous wave was most effective to transfer genes, but cell damage was severe. Duty cycles of 10 and 20% provided almost identical gene transfer efficiency. A duty cycle of 50% increased transfection efficiency significantly. Therefore, a duty cycle of 50% was chosen for our purpose. Second, the ratio of MBs to cells was evaluated. A ratio of 20:1 could not carry out gene transfer efficiently and the ratios of 30:1 and 40:1 provided almost identical gene transfer efficiency. There was no difference between the ratios of 50:1 and 60:1. Thus, 50:1 was chosen. Third, US power and exposure time were studied. Comprehensively considering gene transfer efficiency and cellular damage, a US power of 1 W cm À2 was chosen, and exposure time was set at 60 s. Finally, rAAV2-EGFP transfection efficiency after UTMD was evaluated. There was no difference between the exposure groups at varying power levels ( , 120 s) and the control group. That is to say UTMD had no apparent effect on rAAV2-CMV-EGFP transfection efficiency. The ratios of EGFP-positive cells in the above exposure groups were lower than that of the control group, because some viruses were lost when being transferred from the exposure well to the wells with cells.
Our studies showed that AAV combined with MBs without US or with US exposure alone could not increase transfection efficiency, but UTMD could increase rAAV2 Abbreviation: EGFP, enhanced green fluorescent protein The number of EGFP-positive rats in Group 4 was significantly more than that in other groups (P ¼ 0.029). ; duration, 60 s; duty cycle, 50%; with the ratio of MBs to cells as 50:1. Under this condition, UTMD increased transfection efficiency by approximately 75%, and cell viability was 97.38±3.16%. Furthermore, there was almost no cytotoxicity to rAAV2-CMV-EGFP itself.
Our previous study used methyl thiazolyl tetrazolium assay to measure human RPE proliferation after UTMD for 24 and 72 h. 28, 29 In this study, we used trypan blue assay to measure cell viability immediately after UTMD. The optimal parameters combination that we filtrated was safe not only immediately but also 24 and 72 h after UTMD. Our team members achieved similar trends of UTMD-mediated rAAV2-CMV-EGFP transfection in human renal carcinoma cells in vitro and demonstrated that UTMD-mediated gene delivery occurred principally by enhancing gene entry rather than by the transcription or DNA replication (data not shown). Most reports showed that USMT could enhance gene transfer efficiency, but in our study, USMT did not affect human RPE cells. Perhaps a higher energy was needed for the formation of transient pore in human RPE cells.
In the in vivo study, scholars pay a lot of attention to study USMT on the cornea. Initially, they focused on drug delivery.
14 Recently, gene delivery to the cornea has been studied. A study showed that using US in conjunction with commercially available MBs could enhance gene delivery to the cornea without damaging tissues. 16 Saito et al. 17 found that the degree of cell injury induced by US increased with exposure intensity and duration. Our previous study showed that US combined 
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with SonoVue could safely increase plasmid transfer to the mouse cornea in vivo.
30
In our preliminary experiment in vivo, we used different groupings of power (1, 2 and 3 W cm
À2
) and MBs (1, 2 ml), with a duration of 5 min. We selected 2 W cm À2 and 1 ml MBs as our experimental conditions. Similar to our study in vitro, USMT and MBs alone did not affect the transfection efficiency of the retina in vivo. UTMD could induce rAAV2-mediated EGFP expression earlier after injection and substantially increase gene expression before fastigium (35 days). The difference decreased gradually with an increase in the duration of time. Although the transfection efficiency of Group 4 was higher than that of other groups, there was no difference between them after 35 days. The mechanism by which US enhanced gene delivery was thought to be linked to sonoporation, and UTMD could intensify the bioeffect of sonoporation. Sonoporation provided another method for AAV to enter the cells, and transient pores appeared immediately after US exposure; hence, AAV entered the cells through UTMD earlier and in much more amounts than by natural infection. The fact that UTMD enhanced rAAV2-mediated gene expression in live retina was further confirmed by fluorescent stereoscopic imaging of the rat retina and by fluorescence quantitative methods using Axiovision 3.1 software (ZEISS, Jena, Germany). Integrated optical density (IOD) values showed that UTMD (Group 4) enhanced expression levels by approximately 82, 53, 40, 21 and 16% on the days 4, 7, 35, 49 and 120, respectively compared with natural infection (Group 1). These data strongly suggested the potential utility of UTMD for improving the expression levels of r AAV2-mediated gene transfer in the retina in vivo.
The novelty of our study was that our report described the first successful demonstration that UTMD could be used not only to enhance but also to accelerate transgene expression of the retina. UTMD provided a new method for the systemic administration of AAV vectors.
In this study, we demonstrated that UTMD could enhance AAV transfection efficiency in human RPE cells in vitro and in Wistar rat retina in vivo. The mechanism by which transfection efficiency can be enhanced further and the method by which the amount of AAV that can be attached to MBs can be maximized are worthy of being studied in the future. We only evaluated the tissue structure damage of the retina; a further evaluation of threat to vision is important, especially for eventual clinical application.
Materials and methods
Virus and MBs
The type 2 recombinant AAV vectors encoding the EGFP gene (rAAV2-CMV-EGFP, 1 Â 10 12 vector genomes, vg ml
À1
) were purchased from Vector Gene Technology Company Limited (Beijing, China).
SonoVue (Bracco, Milan, Italy), a lipid-shelled US contrast agent filled with sulfur hexafluoride gas, is composed of approximately 2 Â 10 8 per ml MBs, having an average diameter of 2.5-6.0 mm.
In vitro study Cell culture and in vitro infection. The ARPE-19 (human retinal pigmented epithelium) cell line was obtained from American Type Culture Collection (CRL-2302, ATCC, Rockville, Maryland, USA) and the cells were incubated in Dulbecco's modified Eagle's medium (DMEM; Gibco, Grand Island, NY, USA) supplemented with 10% fetal bovine serum in a 37 1C, 5% CO 2 /95% air environment. Human RPE cells were placed into 24-well plate, only 12-well placed cells, every other well, at a concentration of 2 Â 10 5 cells per well before infection. These cells were infected by rAAV2-CMV-EGFP alone or in combination with US, MBs or UTMD. The cells infected by rAAV2-CMV-EGFP alone served as the control group. In in vitro infection, rAAV2-CMV-EGFP was at 1000 vector genomes per cell (vg per cell).
US exposure protocol. A therapeutic US machine (Topteam161, Chattanooga, America) was used. The area of the probe was 25 mm 2 . The cells were exposed to US (frequency, 1 MHz; power, 1, 2 and 3 W cm
À2
; duration, 60 and 120 s; pulse wave with 10, 20 and 50% duty cycle and continuous wave; pulse recurrent frequency, 100 Hz) with or without MBs. The dosage of SonoVue was selected according to the ratio of MBs to cells (20:1 to 60:1). The US transducer was placed at the bottom of the plates with a small amount of coupling medium on the surface of the probe. A self-made plastic disc with a hole in the middle was placed between the transducer and the bottom of the plates. The purpose of using the self-made plastic disc was to avoid an interaction among the radiated wells, as well as to ensure the same thickness of coupling medium between the probe and the plate. The DMEM volume per well was 150 ml when exposed to US. To attach rAAV2-CMV-EGFP to MBs sufficiently, rAAV2-CMV-EGFP was mixed with MBs in Figure 9 Histology showed no evident tissue damage after ultrasound-targeted microbubble destruction-mediated adeno-associated viral transfection.
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Gene transfer efficiency. At 48 h after transfection, an EGFP expression was observed and photographed using inverted fluorescence microscopy (ZEISS Axiovert S 100). The ratio of the infected cells was examined by FACS (EPICS XL, Beckman Coulter Company, Miami, FL, USA).
Cell viability assay. We performed trypan blue assay immediately after UTMD with various exposure parameters to measure the cytotoxicity of cells. The cells were then analyzed to determine the proportion of positive blue-stained cells through microscopy.
The effect of UTMD on rAAV2-CMV-EGFP. The effect of UTMD on rAAV2-CMV-EGFP itself was evaluated by the transfection efficiency to the cells after UTMD. After 150 ml of medium containing rAAV2-CMV-EGFP only was exposed to varying conditions (power, 1 and 3 W cm À2 ; 50% duty cycle; 60 and 120 s; the ratio of MBs to cells was 50:1), the cells were transfected and transfection efficiency was then evaluated.
In vivo study Animal preparation. Normal adult Wistar rats (180-200 g) were used in this experiment. All animals were treated, maintained and killed in accordance with the policies stated in the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and with the guidelines approved by national and local institutions. The rats were anesthetized with an intraperitoneal injection of 10% chloral hydrate. Pupillary dilatation was achieved by using Tropicamide eye drops. The eyes were gently protruded by a plastic circle and subsequently covered with Ofloxacin eye ointment. A 26-G needle was inserted 1 mm posterior to the corneal limbus, causing a self-sealing wound tunnel under surgical microscopy (SM-2000J, Shanghai, China). A trans-sclera subretinal injection of 3 ml viral suspension was administered by introducing a micro-injector through the sclera and vitreous into the subretinal space. The eyes of the rats were injected with 3 ml rAAV2-EGFP alone or combined with 1 ml MBs or 1 ml normal saline. The doses of the viral vectors were 3 Â 10 9 vg per eye.
Animal grouping
A total of 78 rats were used in this study as follows: In each group, at least five rats survived for more than 4 months. Group 4 was the experimental target and the remaining groups served as controls. Owing to the risk of an overload of volume, we administered the infusions (4 ml) slowly.
US exposure protocol. Right after the subretinal injection, the eyes of Group 3 and Group 4 were exposed to US. The frequency was 1 MHz, US power was 2 W cm À2 and the pulse repetition frequency was 100 Hz, with 50% duty cycle. The entire treatment lasted for 5 min. Histology. Four eyes under US exposure (2 W cm À2 , 1 ml MBs, 5 min) were obtained by an overdose intraperitoneal injection of 10% chloral hydrate administered to four rats on day 4 after subretinal injection. The sections were stained with hematoxylin and eosin to observe retinal architecture by microscopy (ZEISS, Axioplan 2 Imaging). All the specimens were observed by two observers who were blinded to the experiment and received no information about the specimens.
Tissue-stretched preparation of fundus oculi. Two eyes were harvested from each group on day 35. Fundus oculi were prepared after enucleation of the globe by removing the anterior segment with a blade and carefully transferring the whole fundus oculi to a microscope slide. Six relieving incisions were made to allow the retina to be flattened. The tissue was sealed with glycerin. We visualized the transfected tissue by inverted fluorescent microscopy on flat fundus oculi. Two eyes were harvested from the fourth group on day 90. Fundus oculi were prepared as before and the neuroretina was then gently separated from RPE cells. We visualized the neuroretina (with the photoreceptors side down) and the residual fundus oculi (with RPE cells side down) by inverted fluorescent microscopy.
Frozen sections of eyeballs. Two eyes were harvested from each group on day 35 post injection. The enucleated eyes were embedded in OCT compound (Sakura, Torrance, USA) and cryosections (10 mm) were obtained using cryotome (Leica, CM3050S, Wetzlar, Germany). Two eyes were harvested from the fourth group on day 90. Optic cups were prepared after enucleation of the globe by removing the anterior segment, and the neuroretina was then gently separated from RPE cells (detachment of retina). Optic cups were embedded in OCT compound and cryosections (10 mm) were obtained using cryotome. We observed the cryosections by fluorescence microscopy (ZEISS, Axioplan 2 Imaging).
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Statistical analysis
All values were expressed as means and standard deviations (mean ± s.d.). All transfection conditions were performed in three parallel wells following identical procedure and repeated thrice. Independent samples t-test was used to determine the significance of the difference between two groups. ANOVA (analysis of variance) was used to determine the significance of the differences in multiple comparisons. The w 2 -test was used to determine the significance of the measurement data. A value of Po0.05 was considered to be statistically significant. The software package used was SPSS, version 13 (SPSS 13.0, Chicago, USA).
